StockData
Harvard Apparatus Regenerative Technology, Inc. logo

Harvard Apparatus Regenerative Technology, Inc. (HRGN) stock

HRGNOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$2.21−0.02 (-0.72%)

Close on Oct 19, 2026Market cap $38.92MP/E –Yield –

Harvard Apparatus Regenerative Technology price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Harvard Apparatus Regenerative Technology's price to sales ratio was 39.6× on Oct 19, 2026, against 45.2× a year earlier. Over the last 5 years it ranged from 20.7× to 406.2×, with a median of 130.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 202639.6×−2.9
2025Dec 31, 202542.5×−159.4
2024Dec 31, 2024201.9×−32.6
2018Jan 31, 2018234.5×+172.6
2017Dec 29, 201761.8×−183.8
2016Dec 30, 2016245.6×+67.7
2015Dec 31, 2015177.9×−179.0
2014Dec 31, 2014356.9×–

More Harvard Apparatus Regenerative Technology figures

See a number that looks wrong?